Disclaimer (informational only / no trade execution):
El Fondo provides market information, analysis, and performance data strictly for educational and informational purposes. The Platform is read-only and does not allow users to buy, sell, trade, or execute transactions in any asset. El Fondo does not provide investment advice, brokerage services, portfolio management, financial planning, or any other regulated financial service, and nothing on the Platform constitutes a recommendation, solicitation, or offer to buy or sell securities, crypto-assets, or other financial instruments. All investing involves risk, including the possible loss of capital. Past performance is not indicative of future results. Any projections, estimates, or forward-looking statements are provided for illustrative purposes only. Information may come from third parties and may be delayed or inaccurate; we do not guarantee accuracy, completeness, or timeliness. Users are solely responsible for verifying information and making their own decisions. To the fullest extent permitted by applicable law, El Fondo assumes no liability for losses or damages arising from use of the Platform or reliance on its content. We recommend consulting qualified financial, legal, and tax advisors in your jurisdiction before making investment decisions.
Third-Party Brands and Institutional Data
All product names, logos, and trademarks of public companies and third parties are the property of their respective owners. Use of these names and logos on this website is for identification purposes only and does not imply endorsement, sponsorship, or affiliation, unless expressly stated. Institutional investor portfolio data (such as 13F filings) is obtained from official public SEC records. These logos are used strictly for informational purposes to identify the investment manager and do not represent a commercial relationship with El Fondo.
Pfizer announced on October 6, 2026, that its board of directors declared a fourth-quarter 2026 cash dividend of $0.43 per share on the company's common stock.
